Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

J&J issued a press release on January 8, 2025, announcing that "on January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and all U.S.

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

Johnson & Johnson (JNJ) closed down more than -2% to lead losers in the Dow Jones Industrials after Wells Fargo published a research report alleging some disruption to the supply of the company’s ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...